共 176 条
[1]
Benson AB(2004)American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J. Clin. Oncol. 22 3408-3419
[2]
Boland CR(1998)A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res. 58 5248-5257
[3]
Tejpar S(2009)Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial) [abstract] J. Clin. Oncol. 27 a4001-273
[4]
Koopman M(2009)Deficient mismatch repair system in patients with sporadic advanced colorectal cancer Br. J. Cancer 100 266-1206
[5]
Watanabe T(2001)Molecular predictors of survival after adjuvant chemotherapy for colon cancer N. Engl. J. Med. 344 1196-257
[6]
Ribic CM(2003)Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N. Engl. J. Med. 349 247-3415
[7]
French AJ(2008)Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer Clin. Cancer Res. 14 3408-618
[8]
Popat S(2005)Systematic review of microsatellite instability and colorectal cancer prognosis J. Clin. Oncol. 23 609-1750
[9]
Hubner R(2010)Value of mismatch repair, J. Clin. Oncol. 28 a3517-3226
[10]
Houlston RS(2010), and J. Clin. Oncol. 28 a3519-1821